| HOME >> MEDICINE >> TECHNOLOGY |
52,514Goodwill12,993
12,734Intangible assets, net31
34Other assets1,275
1,286Total assets
$
74,962
$
82,308Liabilities and Stockholders' EquityCurrent Liabilities:Accounts payable
$
,845
$
2,399Accrued expenses
2,430
2,209Current portion of long-term debt5,804
5,655Deferred revenue2,649
2,595Total current liabilities12,728
12,858Long-term debt, less current portion20,615
23,110Deferred revenue1,374
2,595Total liabilities34,717
38,563Stockholders' Equity:Preferred stock, $0.01 par value, 50,000,000 shares authorized as of December 31, 2012; none issued or outstanding as of December 31, 2012 and June 30, 2012—
—Common stock, $0.01 par value, 250,000,000 shares authorized as of December 31, 2012; 83,288,081 and 75,849,439 shares issued, and 83,259,411 and 75,820,769 shares outstanding as of December 31, 2012 and June 30, 2012, respectively
833
758Additional paid-in-capital235,720
212,326Accumulated deficit(199,771 )
(172,634 )Accumulated other comprehensive income
3,603
3,435Treasury stock, at cost, 28,670 shares as of December 31, 2012 and June 30, 2012(140 )
(140 )Total stockholders' equity
40,245
43,745Total liabilities and stockholders' equity
$
74,962
$
82,308 UNILIFE CORPORATION AND SUBSIDIARIESConsolidated Statements of Operations(unaudited) Three Months EndedSix Months EndedDecember 31,December 31,2012201120122011(in thousands, except per share data)Revenues:Industrialization and development fees
$
8212;$
249$
8212;$
,689Licensing fees
6636461,3261,318Product sales and other
36176535Total revenues
6999121,3913,042Cost of product sales
22168190Gross profit<
'/>"/>
| SOURCE Unilife Corporation Copyright©2012 PR Newswire. All rights reserved |